CRH (CRH) Stock Forecast, Price Target & Predictions

OverviewRevenue Ownership Financials Chart Transcripts

CRH Stock Forecast

CRH stock forecast is as follows: an average price target of $99.00 (represents a 5.72% upside from CRH’s last price of $93.64) and a rating consensus of 'Buy', based on 11 wall street analysts offering a 1-year stock forecast.

CRH Price Target

The average price target for CRH (CRH) is $99.00 based on 1-year price targets from 11 Wall Street analysts in the past 3 months, with a price target range of $110.00 to $88.00. This represents a potential 5.72% upside from CRH's last price of $93.64.

CRH Analyst Ratings

Buy

According to 11 Wall Street analysts, CRH's rating consensus is 'Buy'. The analyst rating breakdown for CRH stock is 0 'Strong Buy' (0.00%), 8 'Buy' (72.73%), 2 'Hold' (18.18%), 1 'Sell' (9.09%), and 0 'Strong Sell' (0.00%).

CRH Price Target by Analyst

Date	Analyst	Company	Price Target	Price when Published	Price Target/Price when Published	Price Target/Last Closing Price
Aug 09, 2024	Keith Hughes	Truist Financial	$110.00	$82.79	32.87%	17.47%
Jul 09, 2024	Cedar Ekblom	Morgan Stanley	$88.00	$74.23	18.55%	-6.02%
May 13, 2024	Keith Hughes	Truist Financial	$100.00	$83.44	19.85%	6.79%
Dec 14, 2023	Keith Hughes	Truist Financial	$81.00	$67.50	20.00%	-13.50%

The latest CRH stock forecast, released on Aug 09, 2024 by Keith Hughes from Truist Financial, set a price target of $110.00, which represents a 32.87% increase from the stock price at the time of the forecast ($82.79), and a 17.47% increase from CRH last price ($93.64).

CRH Price Target by Period

	1M	3M	12M
# Anlaysts	-	-	3
Avg Price Target	-	-	$99.33
Last Closing Price	$93.64	$93.64	$93.64
Upside/Downside	-100.00%	-100.00%	6.08%

In the current month, the average price target of CRH stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to CRH's last price of $93.64. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades

Date	Company	Previous Rating	New Rating	Rating Change
Oct 29, 2024	Barclays		Overweight	Initialise
Sep 13, 2024	Deutsche Bank	Buy	Buy	Hold
Jul 09, 2024	Morgan Stanley		Overweight	Upgrade
Jun 17, 2024	Stephens		Overweight	Initialise
May 14, 2024	RBC Capital		Outperform	Initialise
Apr 05, 2024	Citigroup	Buy	Buy	Hold
Feb 06, 2023	Citigroup	Buy	Buy	Hold
Feb 06, 2023	Telsey Advisory		Market Perform	Downgrade
Jan 03, 2023	Redburn Partners		Buy	Upgrade
Dec 12, 2022	Goldman Sachs		Sell	Downgrade
Nov 18, 2022	Wedbush		Neutral	Downgrade
Aug 30, 2022	Societe Generale	Buy	Buy	Hold

CRH's last stock rating was published by Barclays on Oct 29, 2024. The company Initialise its CRH rating from "null" to "Overweight".

CRH Financial Forecast

CRH Revenue Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Mar 23	Dec 22	Jun 22	Mar 22	Sep 21	Jun 21
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Avg Forecast	$11.89B	$11.64B	$11.40B	$11.17B	$9.49B	$11.13B	$10.26B	$6.92B	$9.04B	$10.53B	$10.18B	$6.39B	$9.05B	$8.93B	$14.96B	$17.07B	$13.45B	$15.21B	$17.25B	$14.73B
High Forecast	$12.50B	$12.25B	$11.99B	$11.75B	$9.98B	$11.70B	$10.79B	$7.32B	$9.31B	$11.07B	$10.53B	$6.61B	$9.26B	$9.40B	$15.73B	$17.95B	$13.45B	$15.21B	$17.25B	$14.73B
Low Forecast	$11.40B	$11.16B	$10.93B	$10.71B	$9.10B	$10.67B	$9.84B	$6.51B	$8.71B	$10.09B	$9.83B	$6.16B	$8.84B	$8.57B	$14.34B	$16.37B	$13.45B	$15.21B	$17.25B	$14.73B
# Analysts	1	1	1	1	1	1	1	3	5	4	7	7	15	1	1	1	1	1	1	1
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

CRH's average Quarter revenue forecast for undefined based on undefined analysts is $NaN, with a low forecast of $NaN, and a high forecast of $NaN. CRH's average Quarter revenue forecast represents a NaN% decrease compared to the company's last Quarter revenue of $NaN (undefined).

CRH EBITDA Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Mar 23	Dec 22	Jun 22	Mar 22	Sep 21	Jun 21
# Analysts	1	1	1	1	1	1	1	3	5	4	7	7	15	1	1	1	1	1	1	1
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Avg Forecast	$1.87B	$1.83B	$1.80B	$1.76B	$1.49B	$1.75B	$1.62B	$1.09B	$1.42B	$1.66B	$1.60B	$1.01B	$1.43B	$1.41B	$2.36B	$2.69B	$2.22B	$2.50B	$2.84B	$2.43B
High Forecast	$1.97B	$1.93B	$1.89B	$1.85B	$1.57B	$1.84B	$1.70B	$1.15B	$1.47B	$1.74B	$1.66B	$1.04B	$1.46B	$1.48B	$2.48B	$2.83B	$2.22B	$2.50B	$2.84B	$2.43B
Low Forecast	$1.80B	$1.76B	$1.72B	$1.69B	$1.43B	$1.68B	$1.55B	$1.03B	$1.37B	$1.59B	$1.55B	$970.66M	$1.39B	$1.35B	$2.26B	$2.58B	$2.22B	$2.50B	$2.84B	$2.43B
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

undefined analysts predict CRH's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than CRH's previous annual EBITDA (undefined) of $NaN.

CRH Net Income Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Mar 23	Dec 22	Jun 22	Mar 22	Sep 21	Jun 21
# Analysts	1	1	1	1	1	1	1	3	5	4	7	7	15	1	1	1	1	1	1	1
Net Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Avg Forecast	$1.03B	$1.57B	$1.45B	$-37.76M	$996.04M	$1.50B	$1.33B	$-14.88M	$913.47M	$1.29B	$1.15B	$-60.89M	$594.61M	$906.74M	$1.40B	$1.41B	$599.26M	$1.22B	$1.22B	$402.52M
High Forecast	$1.10B	$1.68B	$1.55B	$-35.75M	$1.06B	$1.60B	$1.42B	$-9.92M	$919.64M	$1.38B	$1.19B	$-57.64M	$634.71M	$967.89M	$1.49B	$1.51B	$599.26M	$1.22B	$1.22B	$402.52M
Low Forecast	$971.16M	$1.49B	$1.37B	$-40.31M	$942.86M	$1.42B	$1.26B	$-17.37M	$901.12M	$1.23B	$1.11B	$-64.99M	$562.87M	$858.33M	$1.33B	$1.34B	$599.26M	$1.22B	$1.22B	$402.52M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

CRH's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. CRH's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).

CRH SG&A Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Mar 23	Dec 22	Jun 22	Mar 22	Sep 21	Jun 21
# Analysts	1	1	1	1	1	1	1	3	5	4	7	7	15	1	1	1	1	1	1	1
SG&A	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Avg Forecast	$2.66B	$2.61B	$2.55B	$2.50B	$2.13B	$2.49B	$2.30B	$1.55B	$2.02B	$2.36B	$2.28B	$1.43B	$2.03B	$2.00B	$3.35B	$3.82B	$3.01B	$3.41B	$3.86B	$3.30B
High Forecast	$2.80B	$2.74B	$2.69B	$2.63B	$2.24B	$2.62B	$2.42B	$1.64B	$2.09B	$2.48B	$2.36B	$1.48B	$2.07B	$2.11B	$3.52B	$4.02B	$3.01B	$3.41B	$3.86B	$3.30B
Low Forecast	$2.55B	$2.50B	$2.45B	$2.40B	$2.04B	$2.39B	$2.20B	$1.46B	$1.95B	$2.26B	$2.20B	$1.38B	$1.98B	$1.92B	$3.21B	$3.67B	$3.01B	$3.41B	$3.86B	$3.30B
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

CRH's average Quarter SG&A projection for undefined is $NaN, based on undefined Wall Street analysts, with a range of $NaN to $NaN. The forecast indicates a NaN% fall compared to CRH last annual SG&A of $NaN (undefined).

CRH EPS Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Mar 23	Dec 22	Jun 22	Mar 22	Sep 21	Jun 21
# Analysts	1	1	1	1	1	1	1	3	5	4	7	7	15	1	1	1	1	1	1	1
EPS	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Avg Forecast	$1.49	$2.28	$2.10	$-0.05	$1.45	$2.17	$1.94	$-0.02	$1.33	$1.88	$1.67	$-0.09	$0.86	$1.32	$2.03	$2.05	$0.87	$1.77	$1.77	$0.58
High Forecast	$1.59	$2.44	$2.24	$-0.05	$1.54	$2.32	$2.07	$-0.01	$1.34	$2.01	$1.72	$-0.08	$0.92	$1.41	$2.17	$2.19	$0.87	$1.77	$1.77	$0.58
Low Forecast	$1.41	$2.16	$1.99	$-0.06	$1.37	$2.06	$1.83	$-0.03	$1.31	$1.78	$1.61	$-0.09	$0.82	$1.25	$1.92	$1.94	$0.87	$1.77	$1.77	$0.58
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

According to undefined Wall Street analysts, CRH's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to CRH previous annual EPS of $NaN (undefined).

CRH Peer Comparison by Price Target

Ticker	Company	Last Closing Price	Avg Price Target	Upside/Downside	Avg Rating
CX	CEMEX	$5.62	$7.97	41.81%	Buy
MLM	Martin Marietta Materials	$544.78	$635.20	16.60%	Buy
EXP	Eagle Materials	$266.40	$291.29	9.34%	Buy
VMC	Vulcan Materials Company	$272.65	$290.00	6.36%	Buy
CRH	CRH	$97.23	$99.00	1.82%	Buy
SUM	Summit Materials	$50.77	$48.25	-4.96%	Buy

CRH Forecast FAQ

Is CRH a good buy?

Yes, according to 11 Wall Street analysts, CRH (CRH) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 8 'Buy' recommendations, accounting for 72.73% of CRH's total ratings.

What is CRH's price target?

CRH (CRH) average price target is $99 with a range of $88 to $110, implying a 5.72% from its last price of $93.64. The data is based on 11 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will CRH stock go up soon?

According to Wall Street analysts' prediction for CRH stock, the company can go up by 5.72% (from the last price of $93.64 to the average price target of $99), up by 17.47% based on the highest stock price target, and down by -6.02% based on the lowest stock price target.

Can CRH stock reach $140?

CRH's average twelve months analyst stock price target of $99 does not support the claim that CRH can reach $140 in the near future.

What are CRH's analysts' financial forecasts?

CRH's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $37.79B (high $39.79B, low $36.11B), average EBITDA is $5.95B (high $6.27B, low $5.69B), average net income is $3.81B (high $4.07B, low $3.61B), average SG&A $8.47B (high $8.91B, low $8.09B), and average EPS is $5.53 (high $5.92, low $5.23). CRH's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $46.1B (high $48.49B, low $44.21B), average EBITDA is $7.26B (high $7.64B, low $6.96B), average net income is $4.01B (high $4.28B, low $3.79B), average SG&A $10.33B (high $10.86B, low $9.9B), and average EPS is $5.82 (high $6.22, low $5.5).

Did the CRH's actual financial results beat the analysts' financial forecasts?

Based on CRH's last annual report (Dec 2022), the company's revenue was $32.72B, which missed the average analysts forecast of $45.73B by -28.44%. Apple's EBITDA was $5.68B, missing the average prediction of $7.41B by -23.38%. The company's net income was $2.68B, missing the average estimation of $3.24B by -17.07%. Apple's SG&A was $6.98B, missing the average forecast of $10.24B by -31.81%. Lastly, the company's EPS was $3.54, missing the average prediction of $4.7 by -24.66%.